Ndiaye et al. assessed the expression and localization of ACSL3 and ACSL4 in HCC, cholangiocarcinoma (CCA), and hepatic metastases by performing IHC analyses on tissue microarrays and subcellular fractionation of HepG2 cells [275]. The gene discussed is ACSL3; the disease is hepatocellular carcinoma.